Develops gene therapies for genetic diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Lexeo Therapeutics is a clinical-stage gene therapy company focused on developing treatments for genetic diseases, particularly in cardiovascular conditions and Alzheimer’s disease associated with a specific genetic variation. Their approach involves advancing high-impact genetic medicine candidates, emphasizing efficient development, advanced manufacturing, and strategic partnerships. The company’s pipeline includes programs targeting various genetic conditions affecting the heart and nervous system, as well as Alzheimer’s disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Lexeo Therapeutics Management Team
Lexeo Therapeutics Valuations & Financials
View real-time NPM data on Lexeo Therapeutics stock including daily Lexeo Therapeutics stock price estimates, valuation history, and historical share price information. Access Lexeo Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Lexeo Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Lexeo Therapeutics? Get in touch to learn more.
Similar Companies
like Lexeo Therapeutics
Iris Telehealth
Healthcare & Life Sciences
Telepsychiatry services for community mental health systems.
Trusted
Healthcare & Life Sciences
Digital employment platform built by nurses for nurses.
Nutcracker Therapeutics
Healthcare & Life Sciences
Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.
Rightway
Healthcare & Life Sciences
Guides members to optimal care and medications with personalized navigation and transparent pharmacy benefit solutions.
Brightseed
Healthcare & Life Sciences
Discovers plant-based bioactive compounds to enhance health, providing sustainable solutions for food, beverage, and wellness.
Tempus Labs
Healthcare & Life Sciences
Utilizes AI-driven data integration to deliver personalized medical insights.
FAQ
We have answers
Lexeo Therapeutics stock does not trade on public stock exchanges. Lexeo Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Lexeo Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Lexeo Therapeutics Stock does not trade on public stock exchanges. In order to sell Lexeo Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Lexeo Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Lexeo Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Lexeo Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Lexeo Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Lexeo Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Lexeo Therapeutics is a private company and has not had an IPO. There is currently no Lexeo Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Lexeo Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
